BASTIDE LE CONFORT MEDICAL (BLC.PA) Stock Fundamental Analysis
Europe • Euronext Paris • EPA:BLC • FR0000035370
23.3 EUR
+0.05 (+0.22%)
Last: Feb 2, 2026, 11:33 AM
Taking everything into account, BLC scores 4 out of 10 in our fundamental rating. BLC was compared to 33 industry peers in the Health Care Providers & Services industry. BLC has only an average score on both its financial health and profitability. BLC has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
- BLC had positive earnings in the past year.
- BLC had a positive operating cash flow in the past year.
- BLC had positive earnings in 4 of the past 5 years.
- In the past 5 years BLC always reported a positive cash flow from operatings.
1.2 Ratios
- Looking at the Return On Assets, with a value of 0.08%, BLC is doing worse than 72.73% of the companies in the same industry.
- BLC has a Return On Equity of 0.74%. This is in the lower half of the industry: BLC underperforms 66.67% of its industry peers.
- BLC has a Return On Invested Capital of 6.43%. This is in the better half of the industry: BLC outperforms 75.76% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for BLC is in line with the industry average of 5.90%.
- The last Return On Invested Capital (6.43%) for BLC is above the 3 year average (6.14%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.08% | ||
| ROE | 0.74% | ||
| ROIC | 6.43% |
ROA(3y)0.59%
ROA(5y)1.26%
ROE(3y)4.45%
ROE(5y)9.21%
ROIC(3y)6.14%
ROIC(5y)5.72%
1.3 Margins
- With a Profit Margin value of 0.11%, BLC is not doing good in the industry: 72.73% of the companies in the same industry are doing better.
- BLC's Profit Margin has declined in the last couple of years.
- The Operating Margin of BLC (8.21%) is better than 66.67% of its industry peers.
- In the last couple of years the Operating Margin of BLC has remained more or less at the same level.
- BLC's Gross Margin of 67.80% is fine compared to the rest of the industry. BLC outperforms 75.76% of its industry peers.
- In the last couple of years the Gross Margin of BLC has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.21% | ||
| PM (TTM) | 0.11% | ||
| GM | 67.8% |
OM growth 3Y5.49%
OM growth 5Y0.75%
PM growth 3Y-66.74%
PM growth 5Y-48.72%
GM growth 3Y1.15%
GM growth 5Y6.69%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BLC is still creating some value.
- BLC has about the same amout of shares outstanding than it did 1 year ago.
- The number of shares outstanding for BLC remains at a similar level compared to 5 years ago.
- Compared to 1 year ago, BLC has an improved debt to assets ratio.
2.2 Solvency
- Based on the Altman-Z score of 1.38, we must say that BLC is in the distress zone and has some risk of bankruptcy.
- With a Altman-Z score value of 1.38, BLC perfoms like the industry average, outperforming 42.42% of the companies in the same industry.
- The Debt to FCF ratio of BLC is 12.90, which is on the high side as it means it would take BLC, 12.90 years of fcf income to pay off all of its debts.
- BLC's Debt to FCF ratio of 12.90 is in line compared to the rest of the industry. BLC outperforms 45.45% of its industry peers.
- A Debt/Equity ratio of 5.29 is on the high side and indicates that BLC has dependencies on debt financing.
- BLC has a Debt to Equity ratio of 5.29. This is amonst the worse of the industry: BLC underperforms 84.85% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.29 | ||
| Debt/FCF | 12.9 | ||
| Altman-Z | 1.38 |
ROIC/WACC1.24
WACC5.17%
2.3 Liquidity
- A Current Ratio of 1.38 indicates that BLC should not have too much problems paying its short term obligations.
- The Current ratio of BLC (1.38) is better than 69.70% of its industry peers.
- A Quick Ratio of 1.18 indicates that BLC should not have too much problems paying its short term obligations.
- BLC has a better Quick ratio (1.18) than 72.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.38 | ||
| Quick Ratio | 1.18 |
3. Growth
3.1 Past
- BLC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 158.33%, which is quite impressive.
- Measured over the past years, BLC shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -46.37% on average per year.
- The Revenue has been growing slightly by 6.35% in the past year.
- Measured over the past years, BLC shows a small growth in Revenue. The Revenue has been growing by 5.12% on average per year.
EPS 1Y (TTM)158.33%
EPS 3Y-66.43%
EPS 5Y-46.37%
EPS Q2Q%-107.14%
Revenue 1Y (TTM)6.35%
Revenue growth 3Y1.6%
Revenue growth 5Y5.12%
Sales Q2Q%9.55%
3.2 Future
- Based on estimates for the next years, BLC will show a small growth in Earnings Per Share. The EPS will grow by 6.75% on average per year.
- Based on estimates for the next years, BLC will show a small growth in Revenue. The Revenue will grow by 7.69% on average per year.
EPS Next Y-4.33%
EPS Next 2Y0.96%
EPS Next 3Y6.75%
EPS Next 5YN/A
Revenue Next Year3.87%
Revenue Next 2Y4.87%
Revenue Next 3Y5.16%
Revenue Next 5Y7.69%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 332.86 indicates a quite expensive valuation of BLC.
- Based on the Price/Earnings ratio, BLC is valued a bit more expensive than 72.73% of the companies in the same industry.
- The average S&P500 Price/Earnings ratio is at 28.32. BLC is valued rather expensively when compared to this.
- The Price/Forward Earnings ratio is 11.59, which indicates a very decent valuation of BLC.
- Based on the Price/Forward Earnings ratio, BLC is valued a bit cheaper than 75.76% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of BLC to the average of the S&P500 Index (25.57), we can say BLC is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 332.86 | ||
| Fwd PE | 11.59 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BLC indicates a rather cheap valuation: BLC is cheaper than 87.88% of the companies listed in the same industry.
- BLC's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BLC is cheaper than 81.82% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.39 | ||
| EV/EBITDA | 5.52 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.96%
EPS Next 3Y6.75%
5. Dividend
5.1 Amount
- No dividends for BLC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
BASTIDE LE CONFORT MEDICAL / BLC.PA FAQ
Can you provide the ChartMill fundamental rating for BASTIDE LE CONFORT MEDICAL?
ChartMill assigns a fundamental rating of 4 / 10 to BLC.PA.
Can you provide the valuation status for BASTIDE LE CONFORT MEDICAL?
ChartMill assigns a valuation rating of 4 / 10 to BASTIDE LE CONFORT MEDICAL (BLC.PA). This can be considered as Fairly Valued.
Can you provide the profitability details for BASTIDE LE CONFORT MEDICAL?
BASTIDE LE CONFORT MEDICAL (BLC.PA) has a profitability rating of 5 / 10.
What is the expected EPS growth for BASTIDE LE CONFORT MEDICAL (BLC.PA) stock?
The Earnings per Share (EPS) of BASTIDE LE CONFORT MEDICAL (BLC.PA) is expected to decline by -4.33% in the next year.
Can you provide the dividend sustainability for BLC stock?
The dividend rating of BASTIDE LE CONFORT MEDICAL (BLC.PA) is 0 / 10 and the dividend payout ratio is 106.75%.